Astellas begins phase 3 trials of fezolinetant in postmenopausal women with vasomotor symptoms

Chinese researchers have worked on using existing low molecular weight drugs to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

Researchers in Europe have found no evidence to support previous reports that the use of drugs that target the renin-angiotensin-aldosterone system (RAAS) increases susceptibility to coronavirus disease 2019 (COVID-19)...

Oncological care In Nature Medicine, the seven comprehensive cancer centres of Cancer Core Europe, including the Netherlands Cancer Institute and Cancer Research UK Cambridge Centre, have shared how they rapidly...